Q2 2020 Neurocrine Biosciences Inc Earnings Call Transcript
Good day, everyone, and welcome to today's Neurocrine Biosciences Reports Second Quarter 2020 Results. (Operator Instructions)
It is now my pleasure to turn today's conference over to Todd Tushla, VP of Investor Relations. Please go ahead.
Thank you, Ryland. Good afternoon, everyone, and thank you for joining our Q2 2020 Earnings Call. Joining me on the call is Kevin Gorman, our Chief Executive Officer; Matt Abernethy, our Chief Financial Officer; Eiry Roberts, our Chief Medical Officer; Eric Benevich, our Chief Commercial Officer; and Kyle Gano, our Chief Business Development and Strategy Officer.
During today's call, we'll be making forward-looking statements. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. I encourage you to review the risk factors discussed in our latest SEC filings.
With that, I now turn the call over to Kevin.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |